Microbiota and Pancreatic Cancer Cachexia

NCT05606523 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 24

Last updated 2024-12-06

No results posted yet for this study

Summary

This monocentric study aims at evaluating the effects of fecal microbiota transplantation from newly diagnosed cachectic and non-cachectic pancreatic cancer patients, and healthy volunteers on several cachexia-related parameters of germ-free mice.

Conditions

Sponsors & Collaborators

  • Genton Graf Laurence

    lead OTHER

Principal Investigators

  • Laurence Genton Graf, Prof · Geneva University Hospitals (HUG)

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-08-01
Primary Completion
2025-04-30
Completion
2025-04-30

Countries

  • Switzerland

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05606523 on ClinicalTrials.gov